Endothelial Activation and Stress Index (EASIX) as a Prognostic Tool for Predicting Survival in Advanced-Stage Classical Hodgkin Lymphoma
Hitit Medical Journal · 29.06.2026 · 8 (2) · 386-395
DOI: 10.52827/hititmedj.1846588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hitit Medical Journal, online erschienen am 29.06.2026. Verfasst von Murat Kaçmaz und 4 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Gefördert von: None.
Abstract (Originalsprache)
Background
The prognostic significance of the Endothelial Activation and Stress Index (EASIX) score has been demonstrated in several hematologic malignancies. This study aimed to evaluate the predictive value of the EASIX score for survival outcomes in patients with advanced-stage classical Hodgkin Lymphoma (cHL).Material and Method: This retrospective study included patients with advanced-stage cHL (stage IIB–IV) who received ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) as first-line therapy. EASIX scores were calculated at diagnosis using the formula: serum creatinine (mg/dL) × LDH (U/L) / platelet count (10^9/L).
Results
A total of 85 patients were analyzed. The median age was 36 years, and 61.2% were male. Based on the optimal ROC-derived cutoff value (0.66), 47 patients (55%) were classified into the low-EASIX group and 38 patients (45%) into the high-EASIX group. Progression-free survival (PFS) did not differ significantly between the groups (p = 0.405), and the median PFS was not reached in either group. Similarly, no significant difference in overall survival (OS) was observed (p = 0.295). The median OS for the high-EASIX group was 141.2 months, while it was not reached in the low-EASIX group.
Conclusion
The EASIX score was not associated with survival outcomes in patients with advanced-stage cHL. Further studies with larger cohorts are needed to clarify its prognostic role in this setting.
Förderung
- None
Zitieren
APA
Kaçmaz, M., Yerlikaya, Ş. B., Ural, C., Dogan, A., & Demir, C. (2026). Endothelial Activation and Stress Index (EASIX) as a Prognostic Tool for Predicting Survival in Advanced-Stage Classical Hodgkin Lymphoma. Hitit Medical Journal, 8(2), 386-395. https://doi.org/10.52827/hititmedj.1846588
Vancouver
Kaçmaz M, Yerlikaya ŞB, Ural C, Dogan A, Demir C. Endothelial Activation and Stress Index (EASIX) as a Prognostic Tool for Predicting Survival in Advanced-Stage Classical Hodgkin Lymphoma. Hitit Medical Journal. 2026;8(2):386-395. doi:10.52827/hititmedj.1846588
BibTeX
@article{Kamaz2026,
author = {Kaçmaz, Murat and Yerlikaya, Şengül Baran and Ural, Cihan and Dogan, Ali and Demir, Cengiz},
title = {Endothelial Activation and Stress Index (EASIX) as a Prognostic Tool for Predicting Survival in Advanced-Stage Classical Hodgkin Lymphoma},
journal = {Hitit Medical Journal},
year = {2026},
volume = {8},
number = {2},
pages = {386--395},
doi = {10.52827/hititmedj.1846588}
}
EUVIMED